Covered recipient · General Payments record
ALYSSA CAPAWANA
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$3,485.11
- Reported across 179 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $853.20 | 38 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $617.81 | 28 |
| REVANCE THERAPEUTICS, INC. | $91.57 | 3 |
| Galderma Laboratories, L.P. | $71.86 | 4 |
| Almirall LLC | $32.47 | 1 |
| Lilly USA, LLC | $22.94 | 1 |
| Incyte Corporation | $16.55 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (38)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $20.86 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106875293 | CMS |
| ABBVIE INC. | $3.27 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106875295 | CMS |
| ABBVIE INC. | $3.64 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106875297 | CMS |
| ABBVIE INC. | $26.94 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106875299 | CMS |
| ABBVIE INC. | $15.28 | 01/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106875301 | CMS |
| ABBVIE INC. | $24.36 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106875303 | CMS |
| ABBVIE INC. | $18.77 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106875305 | CMS |
| ABBVIE INC. | $9.43 | 03/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106875307 | CMS |
| ABBVIE INC. | $20.30 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106875309 | CMS |
| ABBVIE INC. | $19.42 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106875311 | CMS |
| ABBVIE INC. | $24.88 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106875313 | CMS |
| ABBVIE INC. | $20.94 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106875315 | CMS |
| ABBVIE INC. | $19.44 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106875317 | CMS |
| ABBVIE INC. | $23.90 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106875319 | CMS |
| ABBVIE INC. | $28.91 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106875321 | CMS |
| ABBVIE INC. | $23.89 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106875323 | CMS |
| ABBVIE INC. | $19.57 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106875325 | CMS |
| ABBVIE INC. | $33.53 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106875327 | CMS |
| ABBVIE INC. | $15.09 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106875329 | CMS |
| ABBVIE INC. | $19.66 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106875331 | CMS |
| ABBVIE INC. | $16.10 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106875333 | CMS |
| ABBVIE INC. | $15.47 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106875335 | CMS |
| ABBVIE INC. | $13.80 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106875337 | CMS |
| ABBVIE INC. | $70.00 | 11/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106875339 | CMS |
| ABBVIE INC. | $25.00 | 11/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106875341 | CMS |
| ABBVIE INC. | $60.00 | 11/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106875343 | CMS |
| ABBVIE INC. | $25.00 | 11/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106875345 | CMS |
| ABBVIE INC. | $0.36 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106875347 | CMS |
| Almirall LLC | $32.47 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120634807 | CMS |
| Galderma Laboratories, L.P. | $18.00 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145348093 | CMS |
| Galderma Laboratories, L.P. | $19.15 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145348095 | CMS |
| Galderma Laboratories, L.P. | $17.22 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145348097 | CMS |
| Galderma Laboratories, L.P. | $17.49 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145348099 | CMS |
| Incyte Corporation | $16.55 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141176394 | CMS |
| Lilly USA, LLC | $22.94 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135445429 | CMS |
| REVANCE THERAPEUTICS, INC. | $25.52 | 03/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147935653 | CMS |
| REVANCE THERAPEUTICS, INC. | $32.17 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147935655 | CMS |
| REVANCE THERAPEUTICS, INC. | $33.88 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147935657 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.